Medicamentos de actualidad = Drugs of today

• 

  Año 2018, Vol. 54, Número 10 / Hauke R. Heekeren (aut.)

  • MONOGRAPHS

    • Apalutamide for the treatment of patients with castration-resistant prostate cancer.

      Hauke R. Heekeren

      • Resumen

      págs. 585-590

      

    • Emicizumab for routine prophylaxis to prevent bleeding episodes in patients with hemophilia A.

      Maribel Díaz Ricart, M. Isola, Ginés Escolar Albadalejo

      • Resumen

      págs. 591-600

      

    • Sodium zirconium cyclosilicate: a new potassium binder for the treatment of hyperkalemia.

      A. Jornet Cases, José Luis Górriz Teruel

      • Resumen

      págs. 601-614

      

  • REVIEW ARTICLE

    • An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib.

      Alfonso Ielasi, Vito Sansone, Ariel Granito, Francesca Benevento, S De Lorenzo, Francesco Tovoli

      • Resumen

      págs. 615-628

      

  • INSIGHT

    • Life sciences licensing deals in the second quarter of 2018: updates and trends.

      P D'Souza

      • Resumen

      págs. 629-638

      

  • NEW PRODUCT INTROS

    • New product intros (albuvirtide, anakinra [new indication], cemiplimab-rwlc, damoctocog alfa pegol, doravirine, doravirine/lamivudine/tenofovir disoproxil fumarate [new combination], duvelisib, pyrotinib maleate, tafenoquine succinate, testosterone gel [new formulation]).

      págs. 639-642